ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · IEX Real-Time Price · USD
1.990
-0.140 (-6.57%)
At close: Jul 19, 2024, 12:00 AM
2.110
+0.120 (6.03%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
ProMIS Neurosciences Employees
As of December 31, 2023, ProMIS Neurosciences had 7 total employees, including 6 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,698,306
Market Cap
39.67M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7 | 0 | - |
Dec 31, 2022 | 7 | 1 | 16.67% |
Dec 31, 2021 | 6 | 5 | 500.00% |
Dec 31, 2020 | 1 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Nortech Systems | 775 |
Co-Diagnostics | 155 |
Owlet | 76 |
electroCore | 68 |
Curis | 49 |
Incannex Healthcare | 10 |
Dyadic International | 7 |
Acurx Pharmaceuticals | 4 |
PMN News
- 2 months ago - ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent Highlights - GlobeNewsWire
- 2 months ago - ProMIS Neurosciences Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed Antibodies - GlobeNewsWire
- 3 months ago - ProMIS Neurosciences Publishes in the Journal of Biological Chemistry on the Interaction Between Pathogenic Proteins as a Treatment Target for ALS - GlobeNewsWire
- 3 months ago - ProMIS Neurosciences to Present in Upcoming Investor Conferences in April - GlobeNewsWire
- 3 months ago - ProMIS Neurosciences Announces Full Year 2023 Financial Results and Recent Highlights - GlobeNewsWire
- 4 months ago - ProMIS Neurosciences Strengthens Global Intellectual Property Portfolio - GlobeNewsWire
- 5 months ago - ProMIS Neurosciences to Present at the 2024 BIO CEO & Investor Conference - GlobeNewsWire
- 6 months ago - ProMIS Neurosciences Achieves Milestone in Development of Therapeutic Alpha-Synuclein Vaccine - GlobeNewsWire